Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology

The aim of this systematic review is to present an up-to-date review of available publications investigating the cellular mechanisms initiating the development of medication-related osteonecrosis of the jaw caused by zoledronic acid. Electronic searches of MEDLINE/PubMed and Scopus were conducted on...

Full description

Bibliographic Details
Main Authors:	Aya Alsalih, Annica Dam, Pia Lindberg, Anna Truedsson
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Dentistry Journal
Subjects:	medication-related osteonecrosis of the jaw MRONJ pathophysiology zoledronate zoledronic acid
Online Access:	https://www.mdpi.com/2304-6767/9/8/85

Similar Items

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
by: Vittorio Fusco, et al.
Published: (2018-09-01)

Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw
by: Winnie Zee Man Wat
Published: (2016-10-01)

Medication-Related Osteonecrosis of the Mandible Treated with Marginal Resection: A Case Report
by: Maciej Chęciński, et al.
Published: (2022-06-01)

Correlations between Immune Response and Etiopathogenic Factors of Medication-Related Osteonecrosis of the Jaw in Cancer Patients Treated with Zoledronic Acid
by: George Adrian Ciobanu, et al.
Published: (2023-09-01)

ZOLEDRONATE-ASSOCIATED RECURRENCE OF OSTEONECROSIS OF JAWS
by: Rosen Tsolov, et al.
Published: (2020-10-01)

Influences of Compressive Force and Zoledronic Acid on Osteoblast Proliferation and Differentiation: An In Vitro Study
by: Kazuyuki Yusa, et al.
Published: (2021-11-01)

Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation
by: Saeed Moradi, et al.
Published: (2023-03-01)

Allogeneic Bone Marrow Mesenchymal Stem Cell Transplantation in Tooth Extractions Sites Ameliorates the Incidence of Osteonecrotic Jaw-Like Lesions in Zoledronic Acid-Treated Rats
by: Francisco Javier Rodríguez-Lozano, et al.
Published: (2020-05-01)

Bisphosphonate-related osteonecrosis of the jaws: Report of two cases with breast cancer, a dental concern and review of the literature
by: Ahmet Ercan Şekerci, et al.
Published: (2012-07-01)

Medication-related osteonecrosis of the jaw in a patient with multiple myeloma
by: Nupur Bhardwaj, et al.
Published: (2015-01-01)

Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures
by: Gioacchino Catania, et al.
Published: (2016-12-01)

Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw
by: Xin Chen, et al.
Published: (2021-11-01)

Absence of medication-related jaw osteonecrosis after treatment with strontium ranelate in ovariectomized rats
by: Leomar Emanuel de Almeida MECCA, et al.
Published: (2022-06-01)

Risk Factors for Medication-Related Osteonecrosis of the Jaw—A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid
by: George Adrian Ciobanu, et al.
Published: (2023-05-01)

Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: Similarities with phossy jaw
by: Giuseppina Campisi, et al.
Published: (2012-01-01)

Osteonecrosis of the jaw during biyearly treatment with zoledronic acid for aromatase inhibitor associated bone loss in early breast cancer: A literature review
by: Hampig Raphael Kourie, et al.
Published: (2015-09-01)

Medication-related osteonecrosis of the jaw using periodontitis-induced rat before tooth extraction
by: Kyeong-Mee Park, et al.
Published: (2023-08-01)

Histopathological assessment of the preventive effect of leukocyte-platelet-rich fibrin on bisphosphonate-related osteonecrosis of the jaw following dental extraction: An animal study
by: Milad Etemadi Sh, et al.
Published: (2023-07-01)

Delayed alveolar bone repair and osteonecrosis associated with Zoledronic Acid therapy in rats: macroscopic, microscopic and molecular analysis
by: Gustavo Zanna FERREIRA, et al.
Published: (2020-09-01)

Oral Complications in Cancer Patients–Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Cesar Augusto Migliorati
Published: (2022-04-01)

Medication‐related osteonecrosis of the jaw and successful implant treatment in a patient on high‐dose antiresorptive medication: A case report
by: Camilla Ottesen, et al.
Published: (2022-10-01)

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
by: Saad Hajeri, BDS, et al.
Published: (2022-09-01)

Calcium Phosphate Ceramics Can Prevent Bisphosphonate-Related Osteonecrosis of the Jaw
by: Siri Paulo, et al.
Published: (2020-04-01)

Autologous Platelet-Rich Fibrin (PRF) as an Adjunct in the Management of Osteoradionecrosis and Medication-Related Osteonecrosis of Jaws. Case Series in A Single Centre
by: Benjie Law, et al.
Published: (2021-04-01)

The Role of Apical Periodontitis Disease in the Development of Bisphosphonate-Related Osteonecrosis of the Jaw: An Animal Study
by: Manuel Marques-Ferreira, et al.
Published: (2023-07-01)

Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study
by: Mohammad Reza Jamalpour, et al.
Published: (2022-06-01)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Sven Otto, et al.
Published: (2021-05-01)

Resective Surgery versus Debridement in Stage 2 Medication-Related Osteonecrosis of the Jaw
by: Salvatore D’Amato, et al.
Published: (2021-09-01)

Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Johannes Laimer, et al.
Published: (2021-05-01)

MicroRNA in medication related osteonecrosis of the jaw: a review
by: Siti Salmiah Mohd Yunus, et al.
Published: (2023-04-01)

Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents
by: Lukas Hauer, et al.
Published: (2020-03-01)

Medication-Related Osteonecrosis of the Jaw in Dental Practice: A Retrospective Analysis of Data from the Milan Cohort
by: Cristina Mirelli, et al.
Published: (2022-05-01)

Medication-Related Osteonecrosis of the Jaws (MRONJ) in Children and Young Patients—A Systematic Review
by: Hemil Dario Rosales, et al.
Published: (2023-02-01)

Zoledronic acid promotes osteoclasts ferroptosis by inhibiting FBXO9-mediated p53 ubiquitination and degradation
by: Xingzhou Qu, et al.
Published: (2021-12-01)

Awareness and practice of dentists in gulf cooperation council countries regarding medication-related osteonecrosis of the jaw – A web-based survey
by: Mohammad Zakaria Nassani, et al.
Published: (2023-10-01)

Local administration of zoledronic acid prevents traumatic osteonecrosis of the femoral head in rat model
by: Jun Zhao, et al.
Published: (2021-03-01)

Treatment of medication-related osteonecrosis of the jaw with cell therapy
by: Cyril Lucien Bouland, et al.
Published: (2024-01-01)

Porphyromonas gingivalis Induces Bisphosphonate-Related Osteonecrosis of the Femur in Mice
by: Shuxuan Wu, et al.
Published: (2022-06-01)

Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases
by: Francesco Erovigni, et al.
Published: (2016-10-01)

Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid
by: Jing Wen Li, et al.
Published: (2022-01-01)